Our study systematically quantified cytokines and intestinal barrier markers (e.g., FABP2, D-lactate, etc.)in feces, providing a non-invasive assessment tool for RA intestinal inflammation and compensating for the limitations of difficult-to-access tissue biopsies. The gene discussed is FABP2; the disease is rheumatoid arthritis.